Quick-Med Technologies, Inc. (QMDT) Stock
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The company’s core technologies include Nimbus, a non-leaching antimicrobial wound dressing material; Stay Fresh, a sequestered hydrogen peroxide-based antimicrobial technology; and superabsorbent antimicrobial materials. In addition, it offers bioguard, DriGo-HP, antimicrobial care products, antimicrobial textiles, and antimicrobial paints and coatings products. Quick-Med Technologies, Inc. was incorporated in 1997 and is headquartered in Gainesville, Florida.
Quick-Med Technologies, Inc. (QMDT) stock trades at $0.00 with a market capitalization of $29877. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of 0.00, price-to-sales of 0.03. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Quick-Med Technologies, Inc. generates a return on equity (ROE) of 11.11%, return on capital employed of 4.78%, an operating margin of -77.01%, a net profit margin of -76.80%.
Official website: www.quickmedtech.com